Using a digital lifestyle tool to prevent cardiovascular events

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves participants who have experienced a myocardial infarction being randomized to either use a digital lifestyle tool for three years or to a control group without access to the tool. The aim is to evaluate the long-term efficacy of this web-based tool in promoting sustainable lifestyle changes and reducing the incidence of major cardiovascular events. The study addresses the need for innovative and cost-effective lifestyle interventions that can be integrated into existing healthcare systems, focusing on patient autonomy and motivation. Participants will be followed prospectively to assess outcomes related to cardiovascular health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age 35 to 80 years
* myocardial infarction within one year prior to enrolment
* access to computer or mobile phone.

Exclusion Criteria:

* conditions or treatments that in the judgement of the Investigator could affect the study evaluation

Where it's running

• Skane University Hospital
  Malmö, Sweden Recruiting

Study contacts

• Principal investigator: Anders Rosengren, Professor — Göteborg University
• Study coordinator: Birgitta Abrahamsson
• Email: birgitta.x.abrahamsson@skane.se
• Phone: 0705316704

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.